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Abstract
Methyllysine histone code readers constitute a new promising group of potential drug targets. For
instance, L3MBTL1, a Malignant Brain Tumor (MBT) protein, selectively binds mono- and di-
methyllysine epigenetic marks (KMe, KMe2) that eventually results in the negative regulation of
multiple genes through the E2F/Rb oncogenic pathway. There is a pressing need in potent and
selective small-molecule probes that would enable further target validation and might become
therapeutic leads. Such an endeavor would require efficient tools to assess the free energy of
protein-ligand binding. However, due to an unparalleled function of the MBT binding pocket (i.e.
selective binding to KMe/KMe2) and because of its distinctive structure representing a small
aromatic “cage”, an accurate assessment of its binding affinity to a ligand appears to be a
challenging task. Here, we report a comparative analysis of computationally affordable affinity
predictors applied to a set of seven small-molecule ligands interacting with L3MBTL1. The
analysis deals with novel ligands and targets, but applies widespread computational approaches
and intuitive comparison metrics that makes this study compatible with and incremental to earlier
large scale accounts on the efficiency of affinity predictors. Ultimately, this study has revealed
three top performers, far ahead of the other techniques, including two scoring functions, PMF04
and PLP, along with a simulation-based method Molecular Mechanics Poisson-Boltzmann/Surface
Area (MM-PB/SA). We discuss why some methods may perform better than others on this target
class, the limits of their application, as well as how the efficiency of the most CPU-demanding
techniques could be optimized.
Introduction
Epigenetic mechanisms are responsible for the cell differentiation and phenotypic changes
under the influence of the environment1. These mechanisms are triggered by a set of post-
translational modifications (“epigenetic marks”) of histone proteins and DNA2. Among
those modifications, histone methylation plays a key role in transcriptional regulation.
Abnormal methylation patterns may lead to various pathologies including cancer1. At the
molecular level, the spatial arrangements of methylation marks (Kme), i.e. the Kme histone
code, act via recruitment of protein complexes (Kme code “readers”) that mediate
transcriptional activation or repression3. Malignant Brain Tumor (MBT) repeats that bind to
methyllysine marks on histone tails4 form the smallest and the least studied class of
“chromatin readers”. Functionally, these proteins localize to chromatin and regulate
transcription by a currently unknown molecular mechanism. For instance, L3MBTL1, a
protein that features three MBT domains, recognizes mono- and di-methyllysine marks on
H1.4K26, H3K4, H3K9, H3K27 and H4K20 in vitro and associates with Heterochromatin
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Protein 1 (HP1γ), and the Retinoblastoma protein (Rb)5. It has been demonstrated that the
Kme recognition by L3MBTL1 occurs in a histone sequence independent manner and is
exclusively mediated by the second MBT domain6. These interactions result in a
transcriptionally nonpermissive chromatin structure in vitro and the negative regulation of
multiple genes through the E2F/Rb oncogenic pathway7, which makes L3MBTL1 and
related MBT-containing proteins a group of attractive therapeutic targets. Hence, there is a
pressing need in potent and selective small-molecule probes that would enable further target
validation and might become leads for therapeutic optimization. Several recent publications
have reported small-molecule MBT antagonists8–10. However, their binding affinities are
relatively weak and need further improvement.
Computational approaches can provide guidance for the optimization of the current hits and
help to identify novel chemical series11. Moreover, recent successes in structure
determination for multiple Kme readers open the avenue for the structure-based design and
virtual screening12. Such an endeavor will require efficient tools for the assessment of the
free energy of protein-ligand binding. However, an accurate assessment of its binding
affinity to a novel ligand may appear to be a challenging task. This challenge is dual: first,
the binding pocket is quite small (i.e. just enough to accommodate a lysine side chain),,
which means that a substantial portion of ligand might be solvent-exposed13; second, the
pocket demonstrates a very intriguing ligand selectivity pattern, i.e. recognizes equally well
both mono- and di-methyl marks (Kme1/Kme2), but completely ignores unmodified (Kme0)
and trimethylated (Kme3) lysine residues. Recently, we have studied how L3MBTL1
discriminates Kme1/Kme2 from Kme0 and Kme3 by means of Molecular Dynamics and
Free Energy Perturbation (FEP) which allowed to predict the relative binding free energies
for the studied ligands9. This study demonstrated that the binding free energies can in
principle be accurately calculated for this class of proteins. However, when it comes to
virtual screening and structure-based design, FEP would not be a viable free-energy
prediction option. First, its computational cost is very high, especially when scaled to
hundreds of ligand-protein complexes. Second, alchemical transformations between ligands
as required by FEP are difficult to automate and can only be applied to relatively similar
ligands. Therefore, there is a need for computationally efficient predictors of the ligand-
protein binding free energy for the histone Kme readers, which constitute a novel class of
potential drug targets.
Here, we report a comparative analysis of computationally affordable free energy predictors
applied to a set of seven small-molecule ligands interacting with L3MBTL1. A relatively
small number of ligands in the test set is because quite few MBT binders have been
published so far. However, these compounds cover a broad range of binding affinities (from
>−2.32 to −7.23 kcal/mol) that is an absolute prerequisite for such a benchmark analysis.
The evaluated predictors were chosen in order to represent various alternative approaches to
free energy calculation. We considered the following the method categories. The first
category includes dynamics-based Molecular Mechanics-Poisson Boltzmann/Surface Area
(MM-PB/SA), Molecular Mechanics-Generalized Born/Surface Area (MM-GB/SA) and
Linear Interaction Energy (LIE). These methods are computationally intensive and allow a
throughput of about 10 ligand-protein complexes a day. Another category includes single
point versions of MM-PB/SA, MM-GB/SA and LIE which do not involve any
conformational sampling and make use of a single conformation, most often obtained from a
fast docking algorithm. These techniques allow to process hundreds of ligands a day and are
generally used as a post-screening rescoring solution. Finally, we have also decided to give a
try to a few scoring functions that are often embedded in docking engines and used for
ranking docking poses and virtual hits. Here again, we selected a representative subset of
popular algorithms. For instance, Dock614 and Autodock415 are illustrative of the force-
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field-based approach, PMF16, PMF0417 are knowledge-based, while PLP18, LigScore19,
Jain20 and GlideSP21 make use of various empirical-based schemas.
We believe that this study is complementary to earlier large scale analyses involving
multiple protein targets and small-molecule ligands such as those performed by Wang et
al22 and Warren et al23. To this end, we have made use of widespread free energy predictors
with standard parameter settings as well as of intuitive comparison metrics such as Pearson’s
R2, Kendall’s τb and Predictive Index (PI).
Materials and Methods
System Setup and Molecular Dynamics Simulation
Molecular system was set up in a similar way as described previously in our paper9 and is
only briefly summarized here. The starting protein structure is the second MBT domain
(residues 366–424) of L3MBTL1 (PDB entry: 2RJF). The protein was treated with Protein
Preparation Wizard module of Maestro21. Initial bound structures were obtained by
superimposing them to the X-ray structure of the dimethylated lysine residue in complex
with L3MBTL1 (PDB entry: 2RJF), followed by a local minimization. The initial bound
structure of compound 7 was obtained from its own X-ray structure (PDB entry: 3P8H)10.
All simulation systems were solvated in an orthorhombic TIP3P water box with a minimum
of 10 Å between the box boundary and any solute atom.
Molecular dynamic simulations were performed using Desmond molecular dynamics
program V2.2 24,25. Particle mesh Ewald (PME) summation26,27 was used to treat long-term
interactions. SHAKE algorithm28,29 was used to restrain all bonds involving hydrogen
atoms. The system was minimized and then gradually heated to 300 K in 0.5 ns. An
additional 0.3 ns simulation at 300 K was performed to further equilibrate the system. Two
independent 20 ns NPT production runs were performed for each receptor-ligand
complexes. System temperature and pressure were regulated by Langevin thermostat and
barostat 30,31. The integration time step was 1 fs, 1 fs, 3 fs for, respectively, the bonded
term, the near term (short-range electrostatic and van der Waals interactions) and the far
term (long range electrostatic interactions). Structure snapshots were saved every 10 ps.
Finally, as required for LIE method, each free-state ligand was also simulated in solution
with a similar procedure.
MM-PB/SA and MM-GB/SA
In MM-PB/SA and MM-GB/SA schemes, the free energy of binding is estimated as:
(1)
Here the molecular mechanics term ΔEMM is the difference between the energy of the
complex and the energies of free-state ligand and receptor in gas phase. ΔGsolv and ΔGSA
are the electrostatic solvation energy and surface area energy change upon ligand binding. In
MM-PB/SA approach, the polar solvation term is computed by iteratively solving Poisson-
Boltzmann (PB) equation, while in MM-GB/SA this term is calculated with the linearized
Generalized Born (GB) model. The last term TΔSconf is the correction accounting for the
conformational entropy loss of the ligand, computed from either normal node or
quasiharmonic analysis. This term is often neglected for structurally similar ligands. The
symbol 〈 … 〉 denotes the ensemble average over a series of conformations, normally
generated by either Molecular Dynamics (MD) or Monte Carlo (MC) simulations. In this
study, a “single-trajectory” approach32 was used. MM-PB/SA and MM-GB/SA calculations
were performed using mm_pbsa.pl as implemented in AMBER 1033. MM-PB/SA rescoring
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was conducted using ZAP34. MM-GB/SA rescoring was computed using Prime MM-GB/SA
module21.
Linear Interaction Energy (LIE)
LIE method estimates the binding free energy based on a linear electrostatic response
approximation and an empirical term accounting for non-polar interactions 35.
(2)
Here ‘l-s’ refers to the interaction energy between the ligand and its surroundings. The two
energy terms were computed from MD trajectories in explicit solvent. α and β are two
adjustable scaling factors, while γ is a constant close to zero. The actual values of α and β
vary in different publications and depend on the modeling system36,37. The values
recommended by the authors of the approach are α ≈ 0.18 and β in the range from 1/3 to
1/237. In the current study, a “vrun” simulation was performed in Desmond in order to
extract the interaction energy between ligand and its surroundings. Similarly to MM-GB/SA,
LIE was later extended to a simplified rescoring process by incorporating a continuum
solvent model38 and by utilizing a single energy minimization39. Here we used the Surface
Generalized Born (SGB)-LIE rescoring model as implemented in Liaison21. In this model,
the electrostatic contribution for the net free energy is computed by the sum of Coulomb
interaction energy (Ecoul) and the SGB-solvent reaction field energy (Erxn).
Statistical criteria
The predictive power of evaluated methods was assessed by three complementary statistical
criteria: 1) Pearson’s R2, 2) Kendall’s τb and 3) the Predictive Index (PI). Kendall’s τb is a
rank-order correlation coefficient and is defined as:
(3)
where nc is the number of concordant pairs of ranks; nd is the number of discordant pairs of
ranks. t and u are the number of tied values in experimental ΔG and predicted ΔG,
respectively.
Predictive index (PI) is a different indicator of rank ordering first described by Pearlman and




Here Ei is the experimental value of ligand i and Pi is the predicted value. The value of PI
ranges from −1 to 1, where 1 means a perfect rank prediction and −1 means a completely
wrong prediction. It is a more sophisticated ranking measure than the Kendall’s τb because it
Gao et al. Page 4













also includes a weighting term that depends on the differences between the consecutive
experimental values.
Results and Discussion
Compound set and experimental data
We selected a total of seven compounds (Table 1) in order to test affordable predictors of
binding free energy to the aromatic cage of L3MBTL1, a representative of methyllysine
reader proteins. Compounds 1 to 4 were designed to mimic four endogenous methylation
states, i.e. N, NMe, NMe2 and NMe3. Compounds 5 (N(Me)Et) and 6 (Pyrrolidine) are two
exogenous alkylated lysine analogs, which bind equally well or better than compounds 2 and
3. Further optimization of compound 6 led to compound 7, which contains a restrained
linker10. Remarkably, despite quite subtle structural differences, these compounds showed a
broad range of binding affinity from >20000 to 5 μM (see Table 1). Five compounds, with
exception of compounds 1 (N) and 4 (NMe3), exhibited a dose-dependent interaction with
L3MBTL1 as measured by Isothermal Titration Calorimetry (ITC). The binding affinities
were in the order of 7 > 6 (Pyrrolidine) > 3 (NMe2) ≈ 5 (NMe(Et)) ≈ 2 (NMe) ≫ 4 (NMe3)
≈ 1 (N).
Free energy predictions
Computational results of our comparative analysis are summarized in Table 2. The results
are arranged in three blocks. In the first block, we considered the most computationally
intensive, dynamics-based techniques, i.e. PB/SA, GB/SA and LIE. Here, FEP results
obtained from our last study are also listed in this block for comparison purposes. The
second block includes single-point versions of the first-block methods that do not require
dynamics simulations. Finally, the third block comprises 10 popular scoring functions
employed by popular virtual screening software. Three popular metrics have been chosen to
express the performance of each method: (i) coefficient of determination or Pearson’s R2 is
a fraction of variance of experimental data that is explained by predicted data; (ii) Kendall’s
τb reflects the similarity of the orderings ranked respectively by experimental and predicted
data; and (iii) predictive index (PI) is a hybrid metrics that quantify both similarities in rank
orderings and the gaps between consecutive experimental values. Each of the three metrics
can be used to rank the predictors from best to worst. As it can be seen from Table 2, all
three ranks converge significantly for three affinity prediction methods – PMF04, PLP and
MM-PB/SA – that can therefore be regarded as top performers in this study. More generally,
we can reasonably assume that all three assessment metrics are important and hence if any
of three coefficients rank a method as a poor performer, this method should tend toward the
bottom of the overall ranking. Following the above logic, and for the convenience of the
data interpretation, Table 2 provides individual ranks for each affinity prediction method
according to each of three assessment techniques, as well as a consensual performance
measure expressed as an average of the three individual ranks. In the next sections, we
propose a detailed comparative analysis of the results obtained and computational protocols
used.
MM-PB/SA outperforms MM-GB/SA
All dynamics-based predictions including MM-PB/SA and MM-GB/SA were obtained by
processing snapshots from two independent 20 ns MD simulations. The gas phase
interaction term ΔEMM, polar solvation term ΔGsolv approximated by PB and GB equations,
as well as the non-polar solvation term ΔGSA are summarized in Supplemental Table 1. The
binding energies predicted by MM-PB/SA are in a good agreement with experimental data
with an R2 value of 0.88 (Table 2 and Figure 1). It also effectively discriminates among the
three apparent groups of weak (1, 4), moderate (2, 3, 5) and stronger (6, 7) binders (as can
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be seen from Figure 1). The only minor inaccuracy is an inversion of the predicted rank
orders for compounds 6 and 7. However, on the energetic scale, MM-PB/SA has predicted
quite unrealistic figures. For example, the predicted affinities of the compounds 2, 3, 5, 6
and 7 lie in the range of ~5.2 kcal/mol (from −31.98 to −26.79 kcal/mol), which is nearly
3.5-fold as compared to the experimentally determined range of ~1.5 kcal/mol (from −5.59
to −7.06 kcal/mol). This large energetic range was also observed when MM-PB/SA is
applied in several other protein systems41,42. Hence, unlike FEP, MM-PB/SA can only be
considered as a ranking tool rather than a true free energy predictor in the case of the KMe
reader L3MBTL1. MM-PB/SA is ranked 2nd according to R2 (0.88), 5th according to τb
(0.68) and 3rd according to PI (0.95) that, with an average rank of 3.3, places it third in the
consensus ranking.
The dynamics-based MM-GB/SA method has shown a significantly lower performance than
MM-PB/SA as instantiated by all three correlation coefficients. Moreover, MM-GB/SA was
not able to discriminate between the weak, moderate and strong binders. For example,
despite a large predicted energetic scale, the computed free energy difference between a
moderate binder 3 (−28.7 kcal/mol) and a non-binder 4 (−28.0 kcal/mol) was just 0.7 kcal/
mol. The only bright spot in the poor outcome of MM-GB/SA predictions was a robust
discrimination between the weakest and the strongest binders. It should be noted that the
mediocre performance of MM-GB/SA is, to some extent, in contrast with the results of a
recent study by Hou et al43. In their comparative analysis performed on a set of six proteins
(structurally different from L3MBTL1), MM-GB/SA was a slightly better predictor than
MM-PB/SA on most protein targets.
MM-PB/SA tolerates short simulation times
We then investigated on how to optimize the computational efficiency of the MM-PB/SA
method. First, we made predictions by means of a single-point version of MM-PB/SA, in
which only a local energy minimization on docking poses was conducted instead of the MD
conformational sampling. In recent years, this method has become a popular rescoring
scheme for the docking-based virtual screening and, according to some reports,
demonstrated a better predictive power as compared to scoring functions embedded in the
docking software44–47. In the current study, the single-point MM-PB/SA was significantly
less predictive than its dynamics-based counterpart (Table 2). Therefore, the next step was to
determine the optimal simulation time. We made use of our 20 ns simulations in order to
calculate MM-PB/SA free energy values at progressively increasing simulation times
starting from 0.1 ns. The plot in Figure 2 demonstrates that even relatively short simulations
lead to high quality predictions. For instance, the shortest tested simulation results in a best
possible compound ranking (PI = 0.95). Additional 3 ns are then necessary to obtain the
highest possible R2.
It is worth to note that a too short simulation may suffer from statistical uncertainty. This is
especially important for MM-PB/SA and MM-GB/SA as these calculations sometimes yield
a large standard deviation of the estimated free energy48. As pointed out by a recent
article48, 1.5 to 15 ns simulation is needed to obtain a statistical precision of 1 kJ/mol (0.24
kcal/mol) for seven complexes of avidin-biotin analogues. This is nearly an order of
magnitude longer than the length of most reported MM-PB/SA simulations. In our study, the
standard deviations of the binding free energies obtained from alternative snapshot
samplings varied from 3 to 5 kcal/mol (Supplemental Table 1), which is quite low compared
to a typical reported values of 5 to 35 kcal/mol48. Hence, at the sampling frequency of 10 ps,
a 3 ns simulation was sufficient to obtain a standard error of mean (SEM) around 0.25 kcal/
mol. Finally, simulation times longer than 3 ns did not result in any increase of the
prediction quality in this study.
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In all simulations the actual data have been collected after a short equilibration time. For
obvious reasons, this equilibration step is especially important for short simulations in order
to “smoothen” unfavorable interactions mainly due to soaking the protein-ligand system in
the explicit solvent medium. In our setting, a 0.3 ns equilibration was sufficient for a
convergent “production” run. However, certain compounds required a longer time. For
example, compound 4 needed at least a 1 ns equilibration, mainly because the bulky tri-
methyl amino group did not fit the initial receptor structure. However, given that compound
4 is a very weak binder, even a partially equilibrated structure did not dramatically affect the
prediction quality.
Deficient performance of LIE
The LIE method was applied in four different settings including the dynamics-based and
single-point protocol, each with either predetermined α and β parameters or fitted to our data
in order to reach a better correlation. None of these protocols has demonstrated an adequate
performance as reflected by all three statistical criteria (Table 2). When using the
recommended parameter set (α = 0.18 and β = 0.50), predicted binding affinities correlated
very weakly with experimental data (R2 = 0.16, τb = 0.43, PI = 0.42). We have also tried to
fit the scaling factors for a better match with experimental binding energies. However, the
fitted parameter set (with α = 0.71 and β = 0.17) only led to an insignificant gain in R2 to
0.29. In terms of compound ranking, LIE method can clearly distinguish two strong binders
6 and 7 from the other five compounds. On the other hand, the binding affinity of
compounds 1 and 4 was overestimated, partially due to an unexpected large electrostatic
term. In addition, LIE incorrectly predicted that there is a large free energy difference
among the three weak binders 2, 3 and 5.
Here we used our previous free energy decomposition results9 to analyze the possible
deficiencies of LIE terms in this test. Although there is no direct one-to-one correspondence,
a qualitative relationship can be anticipated between the polar and non-polar FEP terms and
the two energy terms in LIE. For instance, our previous decomposition suggested that
compound 2 benefits from more efficient vdW interactions and higher bound-state mobility
and that compounds 3, 5 and 6 have a higher electrostatic contribution due to their highly
localized positive charge on the hydrogen pointing to Asp355. In LIE, the relative values of
the vdW term  are clearly correlated with our FEP non-polar contributions
(Supplemental Table 2). On the other hand, the electrostatic term  is practically
uncorrelated to the electrostatic contributions from our FEP study. Moreover, it has already
been reported that LIE may have issues in treating charged ligands, particularly their
electrostatic terms37,49. A possible solution might involve constant pH simulation or a
polarizable force field. Another LIE problem in this study was an excessively high variation
of both energy terms of Equation 2 across different MD snapshots. The latter fact is in
contrast with a relative stability of the MM-PB/SA energy terms, as well as with a good
convergence of our FEP simulations on the same molecular systems9.
In addition to the original LIE scheme, we also examined the single-point LIE method. This
scheme was performed on a single minimized structure with implicit SGB solvation. Using
the default scaling factors, a very pour correlation is found (R2 = 0.34). After fitting the
scaling factors to experimental data, R2 increased to a still low 0.49.
Scoring functions
A total of 10 scoring functions were evaluated in this test, including GlideSP, GlideXP from
Schrodinger21; Ligscore19, PLP18, Jain20, PMF16 and PMF0417, as implemented in
Discovery Studio; Dock6 grid score and contact score in Dock614; as well as AutoDock4
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score15. These 10 scoring functions represent all three major types of energy functions, i.e.
force-field-based, knowledge-based and empirical-based. Before scoring each ligand, we
performed a local minimization to optimize the initial binding pose. In Discovery Studio, a
minimization step by means of the CHARMM force field was performed prior to the scoring
step. In Maestro, Dock6 and AutoDock4, we relied upon native energy minimization
methods intrinsic to the scoring algorithms.
As can be seen from Table 1, the 10 scoring methods performed quite differently in this
study, with R2 ranging from 0.28 to 0.95. Three scoring functions (PLP, PMF04 and
Autodock4) demonstrated a very high R2 value (>0.70). There are three scoring functions
(GlideSP, LigScore and Contact) where the correlation is almost negligible (R2 < 0.40). In
general, the rank-order correlation coefficients τb and PI followed the same trend as that of
R2, which ranks both PLP and PMF04 as the top two performers. However, there are a few
exceptions: for example, GlideSP has a poor R2 value of 0.39, mainly because of a single
outlier (compound 7), while it has correctly ranked the other six molecules that resulted in a
PI value of 0.87. Remarkably, the best scorer, PMF04, is also the best overall performer in
the current study, ahead of computationally demanding MM-PB/SA. However, a larger
number of compounds would be necessary to confirm this finding.
Interestingly, the top scorers represent all three major categories of scoring functions.
Piecewise Linear Potential (PLP) is an empirical function that accounts for all atom-atom
interactions intermolecular interactions18. Potential of Mean Force 04 (PMF04) is a
knowledge-based function derived from statistical analysis of protein ligand complexes16,17.
It outperformed its ancestor, PMF, probably due to a larger parameterization data set.
Autodock4 is a semi-empirical energy function, which combines force field empirical
weights and/or empirical functional forms15. Finally, a force-field-based function, Dock6,
performed moderately well in this test (R2 = 0.62). Dock6 score is a grid-based score
derived from the non-bonded terms of a molecular mechanics force field14.
Six of the ten scoring functions have correctly predicted compound 7 to have the strongest
binding affinity in this set. Among the six functions, only PLP and PMF04 have correctly
ranked compound 6 to be the 2nd strongest binder. Another challenge was to correctly rank
the binding affinities of moderate binders 2, 3 and 5, whose experimental binding free
energies differ only by ~0.2 kcal/mol. Of all scoring functions, only PLP, PMF04 and
GildeSP have correctly predicted these three compounds to have comparable bind affinities.
On the other hand, most scoring functions were correct in ranking compounds 1 and 4 as the
weakest binders. This is likely due to the ability to recognize a weaker electrostatic
interaction with Asp355 that was experimentally demonstrated to be critical for ligand
binding6.
Interestingly, the average R2 over 10 scoring functions amounts to 0.56 that, despite the
novelty of the protein target, is overall superior than what was observed in earlier
benchmark studies on more familiar therapeutic targets22,23. For instance, in a test against
800 diverse protein-ligand complexes, the R2 values demonstrated by 14 energy functions
ranged from 0.02 to 0.3222. The authors have also evaluated the performance of those
scoring functions on three individual targets: HIV-1 protease, trypsin and carbonic
anhydrase II and found that most scoring functions failed to correctly rank ligands. The R2
values ranged from 0.04 to 0.41, with an average of 0.2022. Another study that involved
eight receptors and ten docking programs resulted in R2 values ranging between 0.01 and
0.1623. The authors concluded that “no single program performed well for all of the targets
and none of the docking programs made a useful prediction of the ligand binding affinity”.
In our study, the surprisingly good performance of the standard scoring functions may have
two complementary explanations: (i) scoring functions are subject to continuous
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improvements (e.g., superior performance of PMF04 as compared to the original PMF), (ii)
the MBT binding pocket is relatively small and forms fewer interactions with the ligand as
compared to other proteins that leads to a smaller cumulative error.
Conclusions
In this study, we evaluated how various computational predictors of the ligand-protein
binding affinity perform on a series of seven novel small-molecule binders to a methyllysine
histone code “reader”, L3MBTL1. As a consensus of the comparison metrics used, the study
has revealed three top performers, far ahead of the other techniques. They include two
scoring functions, PMF04 (R2 = 0.95; τb = 1.0; PI = 1.0) and PLP (R2 = 0.80; τb = 0.81; PI =
0.98); and a simulation-based method MM-PB/SA (R2 = 0.88; τb = 0.68; PI = 0.95). It
should be noted that while PMF04 and PLP show excellent results on L3MBTL1, their
performance varies greatly from one protein target to another22,23. Therefore, their general
utility for the KMe histone code readers is still to be confirmed when more experimental
data become available. Alternatively, MM-PB/SA is a less empirical and more CPU-
intensive approach (compared to PMF04 and PLP) with a thorough handling of solvation
effects. Therefore, despite being ranked only third on the current data set, it is more likely to
demonstrate a comparable predictivity on other ligands and proteins similar to those used in
the current analysis. Here, we report a computational protocol that enables an optimal speed-
predictivity ratio when applying MM-PB/SA to histone KMe readers.
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Scatter plots of predicted MM-PB/SA (diamonds) and MM-GB/SA (circles) binding free
energies versus experimental data.
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Impact of simulation time on the predictive power of MM-PB/SA represented by R2
(circles) and PI (diamonds).
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Table 1
Structures of seven designed biophysical probes and their experimental binding affinities to L3MBTL1
N Name R Kd (μM) ΔGExp
1 UNC587 N >20000* >−2.32*
2 UNC588 NMe 104 ± 10 −5.43
3 UNC589 NMe2 73 ± 19 −5.64
4 UNC590 NMe3 >10000* >−2.73*
5 UNC592 N(Me)Et 91 ± 11 −5.51
6 UNC591 Pyrrolidine 21 ± 2 −6.38
7 UNC669 5 ± 1 −7.23
Dissociation constants Kd are measured by ITC and are the average of two independent measurements9, 10. The ITC experiments were performed
at 25°C. Free energy values (ΔGExp) are expressed in kcal/mol.
*
: Neither of compounds 1 and 4 showed any binding interaction in ITC experiment. Hence, their Kd values are estimated from the experimental
detection limit. The relative binding affinities of 1 and 4 were extrapolated from data by Li et al6.
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